Commissioning of volumetric modulated arc therapy (VMAT).
Volumetric modulated arc therapy (VMAT) involves the simultaneous use of dynamic multileaf collimator (DMLC) techniques and gantry arcing; appropriate quality assurance is therefore required. This article describes the development and implementation of procedures for commissioning VMAT on a commercial linear accelerator (Elekta PreciseBeam VMAT with MLCi and Beam Modulator heads). Tests for beam flatness and symmetry at the variable dose rates required for VMAT were performed. Multileaf collimator (MLC) calibration was investigated using dynamic prescriptions. The cumulative dose delivered by a sliding window aperture was measured and compared with calculated values. Rotational accuracy was evaluated using dynamic prescriptions which required accurate correlated motion of both gantry and MLC leaves. Finally, measured and calculated dose distributions for complete VMAT treatment plans were compared and evaluated. Beam symmetry was found to be better than 3% down to dose rates of 75 MU/min. MLC calibration provided continuity of dose at match planes of better than 4%, which was comparable to interleaf leakage effects. Integrated sliding window doses were within 3% of those calculated. Tests for rotational accuracy showed uniformity of peripheral dose mostly within +/-4% of local control point dose, or approximately +/-0.2% of total central dose. A two-arc prostate case showed an absolute dose difference between calculations and measurements of less than 3%, with gamma (3% and 3 mm) of better than 95%. VMAT has been successfully commissioned and has been introduced into clinical use. The Elekta DMLC has also been shown to be suitable for sliding window delivery.